Moderna (MRNA) stock returns by year
Moderna total return by calendar year
| Year | MRNA total return | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +667% | +13.7% | +654 pts |
| 2025 | −29.1% | +17.7% | −46.8 pts |
| 2024 | −58.2% | +24.9% | −83.1 pts |
| 2023 | −44.6% | +26.2% | −70.8 pts |
| 2022 | −29.3% | −18.2% | −11.1 pts |
| 2021 | +143% | +28.7% | +114 pts |
| 2020 | +434% | +18.3% | +416 pts |
| 2019 | +28.1% | +31.2% | −3.1 pts |
Month-end closes adjusted for splits and dividends, through the October 14, 2026 close. Source: Yahoo Finance chart API, monthly close adjusted for splits and dividends. Excludes taxes, fees and inflation. Methodology
Past returns don't repeat. What does the price assume now?
These tables show what already happened. A buyer today gets the next ten years, and the price already reflects what the market expects. The reverse DCF calculator shows the growth today's price implies, so you can judge whether it is realistic.
Frequently asked questions
What was Moderna's best year?
2020, with a total return of +434%. Its worst full year was 2024 at −58.2%.
How often has Moderna gone up in a calendar year?
In 3 of the 7 full calendar years since 2019. It beat the S&P 500 (SPY) in 2 of those years.
How is Moderna doing this year?
+667% from the end of 2025 to the October 14, 2026 close. The S&P 500 (SPY) returned +13.7% over the same stretch.
Do these returns include dividends?
Yes. Each year runs from one December month-end close to the next, using prices adjusted for splits and dividends, so dividends count as reinvested. Taxes, fees and inflation are not included.
Keep exploring
The math is easy. The macro is hard.
Moderna shows the arithmetic. Members get the monthly call that decides which inputs matter, plus written breakpoints when the facts move. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included